Caricamento...
Towards a commercial process for the manufacture of genetically modified T cells for therapy
The recent successes of adoptive T-cell immunotherapy for the treatment of hematologic malignancies have highlighted the need for manufacturing processes that are robust and scalable for product commercialization. Here we review some of the more outstanding issues surrounding commercial scale manufa...
Salvato in:
| Pubblicato in: | Cancer Gene Ther |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356749/ https://ncbi.nlm.nih.gov/pubmed/25613483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2014.78 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|